Latanoprost Production Cost Reports

The report provides a detailed analysis essential for establishing a Latanoprost manufacturing plant. It encompasses all critical aspects necessary for Latanoprost production, including the cost of Latanoprost production, Latanoprost plant cost, Latanoprost production costs, and the overall Latanoprost manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Latanoprost production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Latanoprost is an analog of prostaglandin F2 alpha. It is used in the treatment of open-angle glaucoma. It lowers intraocular pressure and is, therefore, used in ocular hypertension as an antihypertensive agent. It belongs to the class of topical antiglaucoma drugs. Latanoprost is administered in the form of a prodrug. It specifically activates the receptors of prostaglandin F2 alpha and causes a decrease in intraocular pressure due to an increase in the outflow of aqueous humor. It can be formulated with other drugs, such as Netarsudil and Timolol maleate, which would increase its efficacy further. This is why it finds applications in the pharmaceutical and medical industries.

The procurement of Latanoprost is influenced by the fact that it is used in the pharmaceutical and medical industries as an antiglaucoma and antihypertensive agent. The worldwide demand for Latanoprost increases directly due to open-angle glaucoma and other related eye diseases, which are becoming more common these days. Glaucoma, vision flaws, cataracts, and some other eye imperfections are more common among the older demographic group that is more prone to develop them, this consequently boosts ophthalmic drug demands like Latanoprost.

The rising public consciousness with regard to health care is stimulating the activity of periodic eye checkups, hence increasing the probability of early detection of glaucoma, this acts to drive up the demand for the drug. Also, it has better tolerability and fewer side effects compared to other antiglaucoma drugs, therefore, it is more preferred by patients. In general, industrial Latanoprost procurement is influenced by its demand in the pharmaceutical and medical sectors, increasing cases of glaucoma and eye diseases, the aging population, increasing awareness among patients, early diagnosis of glaucoma, better tolerability, and fewer side effects, along with cost-effectiveness, technological advancements, market dynamics, and regulatory approvals.

Raw Material for Latanoprost Production

According to the Latanoprost manufacturing plant project report, the key raw material used in the production of Latanoprost include Benzoyl Corey lactone.

Manufacturing Process of Latanoprost

The extensive Latanoprost production cost report consists of the following major industrial manufacturing process:

• Production from Benzoyl Corey lactone: The manufacturing process of Latanoprost starts by oxidizing benzoyl Corey lactone to an aldehyde using Dess-Martin periodinane. The introduction of the ω side chain is accomplished via an optimized Horner-Wadsworth-Emmons reaction, followed by selective reduction with (−)-diisopinocampheyl chloroborane. Removal of the benzoyl protecting group on the cyclopentane ring is done with potassium carbonate, and the double bond in the ω side chain is hydrogenated with 5% palladium-carbon. Formation of the diol as a tetrahydropyranyl group and synthesis of Latanoprost lactol is performed by reducing the lactone with diisobutylaluminum hydride at −78 °C. Addition of the α side chain is achieved through a Wittig reaction, followed by carboxylic acid alkylation. Removal of THP-protecting groups is accomplished using pyridinium 4-toluenesulfonate. The final Latanoprost is purified from isomeric impurities via normal-phase high-performance liquid chromatography.

Latanoprost, commercially known as Xalatan, has the molecular formula of C26H40O5 and a molecular weight of 432.6 g/mol. Its boiling point is 583.8 °C. Its water solubility is 0.0129 mg/mL. The value of its dissociation constant, pKa, is 4.88. Its log P value is between 3.98-4.44. Latanoprost is a member of the class of compounds known as prostaglandins and associated compounds. It increases the humor outflow by decreasing the intra-ocular pressure. Thus, it is used to treat open-angle glaucoma and ocular hypertension.